Moderna’s COVID-19 vaccine indicates 95.1% ability against virus, 100% in severe cases
Moderna’s COVID-19: One of the companies in the race to produce a vaccine to cure the novel and deadly coronavirus has declared that its drug candidate under trial indicated a 94.1% efficacy against COVID-19 and 100% efficacy in severe cases. According to press publicity issued Monday, American biotechnology company Moderna said its coronavirus drug candidate … Read more Moderna’s COVID-19 vaccine indicates 95.1% ability against virus, 100% in severe cases